 Deutsche Bank AG trimmed its holdings in shares of Jounce Therapeutics Inc NASDAQ:JNCE by 83.3 during the first quarter, according to the company in its most recent Form 13F filing with the Securities Exchange Commission. The institutional investor owned 6,691 shares of the companys stock after selling 33,379 shares during the period. Deutsche Bank ... 